Hyperimmune anti-COVID-19 IVIG (C-IVIG) Therapy for Passive Immunization of Severe and Critically Ill COVID-19 Patients: A structured summary of a study protocol for a randomised controlled trial

Overview of attention for article published in Trials, November 2020

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 tweeters

Citations

dimensions_citation: 11 Dimensions

Readers on

mendeley: 189 Mendeley

Summary Twitter Dimensions citations

So far, Dimensions has found 11 publications that cite this research output.

11

The most recent citing publications are shown below. View all 11 publications that cite this research output on Dimensions.

Convalescent plasma for people with COVID‐19: a living systematic review

Article in Cochrane Database of Systematic Reviews (February 2023)

Intravenous immunoglobulin and treatment in COVID-19 patients: case series

Article in Reviews in Medical Microbiology (February 2022)

Therapeutic role of immunomodulators during the COVID-19 pandemic– a narrative review

Article in Postgraduate Medicine (February 2022)